White Paper
Faster eCOA Development - Insight Brief
Learn more about a new approach to faster eCOA development
Mar 15, 2021

eCOAs improve the quality of data collected from patients and address the need for a more patient-centric trial environment. These assessments capture outcomes from the patient’s perspective through a variety of validated measures, amplifying the patient’s voice while providing sponsors with vital information about the trial experience and patients’ quality of life. This unfiltered approach to collecting patient feedback also provides regulators and payers with new insights into treatment benefits increasing the likelihood of approval and optimal reimbursement.

The value of these tools is undisputed, but the way they are developed by many vendors, using a waterfall methodology of software delivery, is highly inefficient wasting valuable time and increasing the likelihood of downstream design changes, defects, and ultimately causing delays in being ready for first-patient-in.

IQVIA evolved eCOA development to cut months from the trial planning process, accelerate first patient in, and help sponsors reduce time, cost, and risk in the trial environment – to ultimately become another tool to help bring new therapies to patients faster.

Related solutions

Contact Us